NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » whitepapers » Investment in supply-chain visibility reduces cost

White Paper

Investment in supply-chain visibility reduces cost

A risk-based approach to monitoring investigational medicinal products can help pharmaceutical companies improve supply chain efficiency, but to do this without compromising quality relies fast access to comprehensive shipment data. Using cloud temperature monitoring solution – CCIS – and data loggers from TSS, GlaxoSmithKline has saved £4 million annually. Clinical Trials Insight hears from Rob Montague, director of supply chain logistics – IMP at GSK; and Niclas Ohlsson, CEO of TSS.

Download to find out more.

Download White Paper